138 related articles for article (PubMed ID: 11238106)
1. Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis.
Yamada Y; Takakura N; Yasue H; Ogawa H; Fujisawa H; Suda T
Blood; 2001 Mar; 97(6):1671-8. PubMed ID: 11238106
[TBL] [Abstract][Full Text] [Related]
2. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.
Hamada K; Oike Y; Takakura N; Ito Y; Jussila L; Dumont DJ; Alitalo K; Suda T
Blood; 2000 Dec; 96(12):3793-800. PubMed ID: 11090062
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.
Miao HQ; Soker S; Feiner L; Alonso JL; Raper JA; Klagsbrun M
J Cell Biol; 1999 Jul; 146(1):233-42. PubMed ID: 10402473
[TBL] [Abstract][Full Text] [Related]
4. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1.
Fuh G; Garcia KC; de Vos AM
J Biol Chem; 2000 Sep; 275(35):26690-5. PubMed ID: 10842181
[TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
Soker S; Takashima S; Miao HQ; Neufeld G; Klagsbrun M
Cell; 1998 Mar; 92(6):735-45. PubMed ID: 9529250
[TBL] [Abstract][Full Text] [Related]
6. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
[TBL] [Abstract][Full Text] [Related]
7. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
8. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
[TBL] [Abstract][Full Text] [Related]
9. Endothelial growth factor receptors in human fetal heart.
Partanen TA; Makinen T; Arola J; Suda T; Weich HA; Alitalo K
Circulation; 1999 Aug; 100(6):583-6. PubMed ID: 10441093
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1.
Wise LM; Veikkola T; Mercer AA; Savory LJ; Fleming SB; Caesar C; Vitali A; Makinen T; Alitalo K; Stacker SA
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3071-6. PubMed ID: 10077638
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
[TBL] [Abstract][Full Text] [Related]
12. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
[TBL] [Abstract][Full Text] [Related]
13. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.
Beck H; Acker T; Püschel AW; Fujisawa H; Carmeliet P; Plate KH
J Neuropathol Exp Neurol; 2002 Apr; 61(4):339-50. PubMed ID: 11939589
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways induced by vascular endothelial growth factor (review).
Larrivée B; Karsan A
Int J Mol Med; 2000 May; 5(5):447-56. PubMed ID: 10762646
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish.
Lee P; Goishi K; Davidson AJ; Mannix R; Zon L; Klagsbrun M
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10470-5. PubMed ID: 12142468
[TBL] [Abstract][Full Text] [Related]
17. Receptor links blood vessels, axons.
Roush W
Science; 1998 Mar; 279(5359):2042. PubMed ID: 9537914
[No Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121).
Whitaker GB; Limberg BJ; Rosenbaum JS
J Biol Chem; 2001 Jul; 276(27):25520-31. PubMed ID: 11333271
[TBL] [Abstract][Full Text] [Related]
19. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.
Tao Q; Backer MV; Backer JM; Terman BI
J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation.
Carlevaro MF; Cermelli S; Cancedda R; Descalzi Cancedda F
J Cell Sci; 2000 Jan; 113 ( Pt 1)():59-69. PubMed ID: 10591625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
